Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Assertio

Biotech & Life Sciences · Newark, United States · Founded 1995 · IPO 1997 Thoroughbred

A leading commercial pharmaceutical company bringing differentiated products to patients

Valuation
$96M
Market cap · May/2026
Revenue
$119M
Latest reported FY
EBITDA
$21M
Latest reported FY

Global footprint

Where Assertio has talent and traffic

Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown
Web traffic by country
3.7K monthly visits
across markets
🇺🇸 United States83.8%
🇮🇳 India16.2%
Top 2 markets shown

Market sentiment

What the market is saying about Assertio

An AI-synthesized read of the highest-engagement posts about Assertio on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Assertio on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.